Close Menu

Amgen

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Warnex today said that it has signed an agreement to serve as exclusive distributor of 10 of DeCode Genetics' tests in Canada.

Movers & Shakers: Sep 23, 2011

Premium

Quanterix this week appointed Martin Madaus as CEO. Madaus had been serving as the company's acting CEO and chairman of the board of directors, a position that he will retain.

Originally published August 18.
By Turna Ray

Advanced sequencing technologies are great for discovery, but not ready to be incorporated into Qiagen's commercial companion diagnostics portfolio, according to CEO Peer Schatz.

"Courts are willing to require the use and understanding of genetic information even before the medical community itself is ready and able to do so," according to researchers from Arizona State University who are tracking increasing liability risk for doctors within the context of genomic medicine.

EGFR has emerged as a primary area of interest in cancer research, with biopharmaceuticals like Imclone's Erbitux and Amgen's Vectibix targeting the protein, but its multiple isoforms have made it difficult to predict these drugs' effectiveness, said Yale professor Nita Maihle.

"We are always looking at entities, particularly DTC companies, who may be marketing APOE tests without a sublicense from Athena, are making misleading representations of those tests and their clinical interpretations, and are generally violating patent claims we own and have licensed, accordingly," said a Duke spokesperson.

The "opt-in" model ensures that customers are aware of the risks and limitations of this potentially sensitive data, but some are questioning whether the direct-to-consumer model is the appropriate mechanism for delivering information on APOE status, even with additional precautions.

A Cleveland Clinic official recently discussed three investigations that have added to the body of knowledge about how genomic medicine should be adopted into the existing healthcare infrastructure.

Pages

Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.

Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.

Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.

In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.